ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2019-2027

Market By Products, Applications, End-users And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific immunohistochemistry market is expected to display an upward trend and is estimated to progress at a CAGR of 7.36% over the forecast period of 2019-2027.

Countries covered in the Asia-Pacific immunohistochemistry market:

•           China

•           Japan

•           India

•           South Korea

•           ASEAN countries

•           Australia & New Zealand 

•           Rest of Asia-Pacific

To get detailed insights on segments, Download Sample Report

Academic research in China is on the constant rise as it is being well funded and a substantial precision medicine initiative has also been taken up by the Chinese government which is anticipated to provide around $9.2 billion mainly focusing on cancer research providing potential opportunities considering the IVD scenario. The constant rise in the prevalence of cancer in China is acting as a key driver in the growth of the immunochemistry market in the country. The prevalence of lung cancer is the leading cause of cancer deaths in the country. Owing to its surging incidence and mortality, cancer is one of the leading causes of death in China and is a critical public health issue. The highest rate of geriatric population in the country is also impacting the growth of the immunohistochemistry market in the country.

The biotech industry is on the constant rise and is anticipated to experience significant growth considering the favorable business conditions in the country. The upsurging biotech industry in the country is paving the way for the growth of the immunochemistry market in India. The escalating government expenditure is also likely to fuel the growth of the biotechnology industry in India. Moreover, the rising pharmaceutical industry is positively impacting the growth of the biotech industry in the country. In the present scenario, public funding is being offered for research & product innovation considering the biotech sector in the country.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    IMMUNOHISTOCHEMISTRY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. HISTORY OF IMMUNOHISTOCHEMISTRY

2.3. VALUE CHAIN OUTLOOK

2.4. KEY INSIGHTS

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. MARKET DRIVERS

2.6.1.   IN-VITRO TECHNOLOGICAL ADVANCEMENTS

2.6.2.   INCREASING CANCER OCCURRENCE

2.6.3.   SWELLING HEALTHCARE SPENDING

2.6.4.   INCREASING USAGE OF POC TESTING

2.7. MARKET RESTRAINTS

2.7.1.   RESTRICTIONS OF CLOSED SYSTEMS

2.7.2.   REIMBURSEMENT ISSUES

2.8. MARKET OPPORTUNITIES

2.8.1.   INCREASING USAGE OF BIOMARKERS FOR DISEASE DIAGNOSIS

2.8.2.   TECHNOLOGICAL ADVANCEMENTS

2.9. MARKET CHALLENGES

2.9.1.   HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH

3.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS

3.1. ANTIBODIES

3.1.1.   PRIMARY ANTIBODIES

3.1.2.   SECONDARY ANTIBODIES

3.2. EQUIPMENT

3.2.1.   SLIDE STAINING SYSTEMS

3.2.2.   TISSUE MICROARRAYS

3.2.3.   TISSUE PROCESSING SYSTEMS

3.2.4.   SLIDE SCANNERS

3.2.5.   OTHER EQUIPMENT

3.3. REAGENTS

3.3.1.   HISTOLOGICAL STAINS

3.3.2.   BLOCKING SERA AND REAGENTS

3.3.3.   CHROMOGENIC SUBSTRATES

3.3.4.   FIXATION REAGENTS

3.3.5.   STABILIZERS

3.3.6.   ORGANIC SOLVENTS

3.3.7.   PROTEOLYTIC ENZYMES

3.3.8.   DILUENTS

3.4. KITS

4.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS

4.1. DIAGNOSTICS

4.1.1.   CANCER

4.1.2.   INFECTIOUS DISEASES

4.1.3.   CARDIOVASCULAR DISEASE

4.1.4.   AUTOIMMUNE DISEASES

4.1.5.   DIABETES MELLITUS

4.1.6.   NEPHROLOGICAL DISEASES

4.2. DRUG TESTING

5.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS

5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES

5.2. RESEARCH INSTITUTES

5.3. OTHER END-USERS

6.    IMMUNOHISTOCHEMISTRY (IHC) REGIONAL OUTLOOK - ASIA-PACIFIC

6.1. COUNTRY ANALYSIS

6.1.1.   CHINA

6.1.2.   INDIA

6.1.3.   JAPAN

6.1.4.   SOUTH KOREA

6.1.5.   AUSTRALIA & NEW ZEALAND

6.1.6.   ASEAN COUNTRIES

6.1.7.   REST OF APAC

7.    COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ABCAM PLC

7.3. AGILENT TECHNOLOGIES, INC.

7.4. BIOGENEX

7.5. BIO-RAD LABORATORIES, INC.

7.6. BIO SB

7.7. CELL SIGNALING TECHNOLOGY, INC.

7.8. DANAHER CORPORATION

7.9. F. HOFFMANN-LA ROCHE AG

7.10.            HISTOLOGIX

7.11.            MERCK MILLIPORE

7.12.            PERKINELMER, INC.

7.13.            SIEMENS AG HEALTHCARE

7.14.            THERMO FISHER SCIENTIFIC, INC.

8.    METHODOLOGY AND SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        ASIA-PACIFIC MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)

TABLE 2        CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

TABLE 3        ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 4        ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)

TABLE 5        CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

TABLE 6        SECONDARY ANTIBODY SELECTION

TABLE 7        ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)

TABLE 8        ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)

TABLE 9        HISTOLOGY STAINS AND ITS CATEGORIES

TABLE 10      COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

TABLE 11      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

TABLE 12      KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION

TABLE 13      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)

TABLE 15      SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

TABLE 16      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 17      IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY

TABLE 18      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      ASIA-PACIFIC MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)

FIGURE 2      HISTORY OF IMMUNOHISTOCHEMISTRY

FIGURE 3      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 4      ASIA-PACIFIC ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 5      ASIA-PACIFIC ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 6      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 7      ASIA-PACIFIC EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 8      ASIA-PACIFIC EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)

FIGURE 9      ASIA-PACIFIC EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 10   ASIA-PACIFIC EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)

FIGURE 11   ASIA-PACIFIC EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2019-2027 ($ MILLION)

FIGURE 12   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)

FIGURE 13   ASIA-PACIFIC REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)

FIGURE 14   ASIA-PACIFIC REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)

FIGURE 15   ASIA-PACIFIC REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)

FIGURE 16   ASIA-PACIFIC REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)

FIGURE 17   ASIA-PACIFIC REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)

FIGURE 18   ASIA-PACIFIC REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)

FIGURE 19   ASIA-PACIFIC REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)

FIGURE 20   ASIA-PACIFIC REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)

FIGURE 21   PHASES OF HISTOLOGICAL STAINING

FIGURE 22   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

FIGURE 23   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 24   ASIA-PACIFIC DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)

FIGURE 25   ASIA-PACIFIC DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)

FIGURE 26   ASIA-PACIFIC DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)

FIGURE 27   ASIA-PACIFIC DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)

FIGURE 28   ASIA-PACIFIC DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)

FIGURE 29   ASIA-PACIFIC DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)

FIGURE 30   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)

FIGURE 31   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 32   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)

FIGURE 33   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2019-2027 ($ MILLION)

FIGURE 34   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 35   CHINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 36   INDIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 37   JAPAN IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 38   SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 39   AUSTRALIA & NEW ZEALAND IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 40   ASEAN COUNTRIES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 41   REST OF APAC IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;